Taiwan's Biobusiness Asia Conference Draws Big Pharma Looking For Perfect Biotech Match
This article was originally published in PharmAsia News
TAIPEI - Novo Nordisk's Tomas Land was in Taiwan this week hoping to give money away
You may also be interested in...
TAIPEI - Taiwan is making a serious push to create a biosciences hub. The government is not only spending plenty of money but it is also creating a welcoming regulatory environment and a relatively safe legal framework that can take some of the risk out of investing in China, speakers told BioBusiness Asia attendees in Taiwan July 21
[Editor's note: This is part three in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes, and access to medicines. Part one in the series appeared in PharmAsia News Oct. 30, 2008, and part two appeared Nov. 13, 2008.]
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).